|
|
|
Volumn 96 Suppl 1, Issue , 2001, Pages 17-21
|
|
Early multiple sclerosis therapy in the effects of public health economics;Frühe Multiple-Sklerose-Therapie und ihre gesundheitsökonomischen Auswirkungen.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA INTERFERON;
BETA1A INTERFERON;
INTERFERON BETA SERINE;
INTERFERON BETA-1B;
ARTICLE;
COST BENEFIT ANALYSIS;
COST OF ILLNESS;
ECONOMICS;
GERMANY;
HUMAN;
MULTIPLE SCLEROSIS;
PUBLIC HEALTH;
COST OF ILLNESS;
COST-BENEFIT ANALYSIS;
GERMANY;
HUMANS;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
NATIONAL HEALTH PROGRAMS;
|
|
EID: 0035885825
PISSN: 07235003
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|
